By the end of 2002, Bayer AG of Germany plans to introduce its version of Viagra called Vardenafil. Bayer claims that this drug will be a safer and more tolerable alternative to Viagra. Currently in phase III of clinical trials, Vardenafil is being tested on 3,000 men. In phase II, Vardenafil was tested on 600 men in